FDA Investigator Langer
Langer has inspections in 1 countries as of 29 Sep 2023. Langer has collaborated with a combined 3650 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
97
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aaron J Adler,
Adam S Freeman,
Ademola O Daramola,
Alan L Truong,
Alan P Kurtzberg,
Albert C Cheng,
Alexandra B Pitkin,
Amalia C Himaya,
Amanda L Fyles,
Anderson,
Andrea A Branche,
Andrew K Haack, PhD,
Andy B Lee,
Angela Shepas,
Anh M Lac,
April C Inyard,
Arie C Menachem,
Armando Chavez, MS,
Arsen Karapetyan,
Ashar P Parikh,
Babajide Michael Osunsanmi,
Barbara J Rincon,
Bichsa T Tran,
Binh T Nguyen,
Brian P Putz,
Bryan A Galvez,
Bryan L Mcguckin,
Bush,
Carla J Lundi,
Carlos Chavez,
Carolina D Vasquez,
Carr Sharpe,
Carrie A Hughes,
Caryn M Everly,
Caryn M Mcnab,
Cassandra L Abellard,
Cecilia H Kieu,
Celena Ngo,
Charles I Ann,
Chelsea N Sealey,
Christopher J Freebairn,
Christopher M Hernandez,
Christopher M Jenner,
Christopher R Czajka,
Claudia Mperez Kasmarski,
Comyar Shoghi,
Cynthia F Kleppinger, MD,
Dan G Eisenbrey,
Daniel R Solis,
Darren S Brown,
Darrin E Davis,
David Serrano,
Deborah A Greco,
Deborah W Hsu,
Diane Cvan Leeuwen,
Diane L Raccasi,
Diane R Weidley,
Dogbeda F Mackenzie,
Donna Ltartaglino Besone,
Donna Mwilliams Hill,
Dr. Chunchang Fang,
Dustin P Tran,
Edwin Melendez,
Eileen A Liu,
Esteban Beltran,
Evelyn Wong,
Gabriel Guevarra,
Gabriel M Guevarra,
Gam S Zamil,
Garciam,
Gene D Arcy,
Geraldine H Matining,
Geraldine M Peregrin,
Glen C Lawrence,
Greg K Keshishyan,
Haroon Vohra (NMI),
Heidy C Perales,
Heika R Tait,
Hung H Do, MS,
Jacqueline C Sram,
Jai P Singh,
James A Barreto,
James B Arnett,
James R Fleckenstein,
Jamie M Du,
Jane S Wernberg,
Jazmine M Welcher,
Jeffery A Johnson,
Jeffrey P Raimondi,
Jeffrey W Shrifter, DPM,
Jennifer M Gogley,
Jinnie Kokiatkulkij,
Jocelyn E Massey,
Jocelyn E Sparks,
Joel D Hustedt,
Joey V Quitania,
John A Gonzalez,
John L Stevens,
Jolanna A Norton,
Juan J Casado,
Juanita Banuelos,
Jude C Dikes,
Judy C Nepsa,
Justin A Boyd,
Ka L Wong,
Karen P Langer,
Kari M Johansen,
Katherine E Jacobitz,
Keith P Iams,
Kelley,
Kelvin Cheung,
Kelvin X Sanders,
Kelvin X Saunders,
Kevin N Tran,
Kevin P Foley,
Kham Phommachanh,
Khoa Nathanv Tran,
Kim Lthomas Cruse,
Kirtida Patel,
Kouros Kangarli,
Lakecha Lewis,
Lakecha N Lewis,
Lance A Finnical,
Lanita F Kelley,
Leonard H Lavi,
Lillian S Wu,
Lilly O Barton,
Liming Zhang,
Linda F Murphy,
Linda L Ng,
Linda Thai,
Lisa Shin,
Louis B Cencetti,
Louise B Cencetti,
Marcus F Yambot,
Marie Falcone,
Marie T Falcone,
Mariza M Jafary,
Mark A Tucker,
Mark C Saale,
Marlo Ianm Alintanahin,
Mary Ewilkerson Brinsko,
Matthew J Johnson,
Matthew R Clabeaux,
Maurice M Sheehan,
Maxyne Lam,
Maxyne T Lam,
Michael D Garcia,
Michael T Cyrus,
Miguel A Martinez,
Mihaly S Ligmond,
Minh D Phan,
Nancy E Byerly,
Nancy E Smith,
Natalie J Ayoub,
Natalie J Reese,
Nayan J Patel,
Nicholas L Hunt,
Pal S Mayasandra,
Patricia F Alberico,
Prabhu P Raju,
Raymond T Oji,
Richmond K Yip,
Robert C Coleman,
Rocio Guzman Velazquez,
S Lori Brown, PhD MPH,
Saied A Asbagh,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Santos E Camara,
Sarah A Hassas,
Scott K Zika,
Sean P Desbrow,
Selene T Torres,
Shelley H Beausoleil,
Sidney B Priesmeyer,
Sonia R Peterson,
Sonya L Karsik,
Stacie A Woods,
State Agency,
Stephanie A Slater, MS,
Steven E Porter, Jr,
Sudipan Karmakar,
Sundy V Sedwick,
Sundy Ven,
Sunita Masson,
Sunita Vij,
Susan F Laska, MS,
Susan K Bain,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Teresa T Cain,
Terrance L Thomas,
Terrance P Nguyen,
Terri L Dodds,
Thao T Kwan,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vashti E Bocker,
Vickie L Anderson,
Virgilio F Pacio, CSO,
Walden H Lee,
William J Leonard,
Yasamin Ameri,
Yumi J Hiramine,
Yvette E Guillermo,
Yvette Mlacour Davis,
Yvins Dezan,
Zachary A Bogorad,
Zachary L Miller
Langer's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2002 | FDA 483 | NB & T Industries Inc - Form 483, 2002-10-23 |
December, 2002 | FDA 483 | Spatz Corp Dba Spatz Laboratories - Form 483, 2002-12-18 |
July, 2003 | EIR | Constant Irwindale Inc. - EIR, 2003-07-07 |
October, 2002 | FDA 483 | Westwood Laboratories, Inc. - Form 483, 2002-10-09 |
October, 2002 | EIR | Vita-Herb - EIR, 2002-10-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more